FOUNTAIN VALLEY, CALIFORNIA -- (MARKET WIRE) -- January 23, 2007 -- Sutura, Inc. ("Sutura") (OTCBB: SUTU), an innovative developer of minimally invasive vascular suturing devices, announced today it has successfully completed a PFO Test of its HeartStitch™ suturing device. During the test, Sutura successfully closed the PFO (Patent Foramen Ovale) in a porcine model. The test was conducted by two of Sutura's senior medical advisors Dr. Carlos Ruiz and Dr. John Crew, who successfully placed the new HeartStitch device through the PFO and sutured it closed.
